Goserelin acetate implant, per 3.6 mg
Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.
ZOLADEX is an Oncology drug manufactured by Tersera Therapeutics and administered via the Subcutaneous route of administration. The J Code: J9202 is aligned to the drug ZOLADEX.
January 1, 1991
January 1, 1997